First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy

doi:10.12998/wjcc.v8.i18.4022

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4405)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

280

WORD

130

HTML

1918

Figures (1-2)

157

Tables (1-5)

219

Sum=2704

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

604

Download

1097

Sum=1701

Sep 26, 2020 (publication date) through May 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Cases. Sep 26, 2020; 8(18): 4022-4033
Published online Sep 26, 2020. doi: 10.12998/wjcc.v8.i18.4022

Open in New Tab Full Size Figure Download Figure

Figure 1 Progression-free survival (A) and overall survival (B) of each regimen in elderly patients. FFX: FOLFIRINOX; G mono: Gemcitabine monotherapy; GA: Gemcitabine plus nab-paclitaxel.

Open in New Tab Full Size Figure Download Figure

Figure 2 Progression-free survival (A) and overall survival (B) of each regimen in very elderly patients. FFX: FOLFIRINOX; G mono: Gemcitabine monotherapy; GA: Gemcitabine plus nab-paclitaxel.

Citation: Han SY, Kim DU, Seol YM, Kim S, Lee NK, Hong SB, Seo HI. First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy. World J Clin Cases 2020; 8(18): 4022-4033
URL: https://www.wjgnet.com/2307-8960/full/v8/i18/4022.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i18.4022